Bohemia, NY (PRWEB) December 29, 2012
On December 29, Voices Against Brain Cancer (VABC) issued a response to new research that was conducted at St. Joseph's Hospital and Medical Center in Phoenix, Arizona.
The article from Medical News Today said that “brain cancer researchers have successfully treated mice with malignant gliomas, a type of aggressive and deadly brain tumor, with a unique combination of radiation therapy and ketogenic diet, a high fat, low carbohydrate and minimal protein regime that forces the body to use fat instead of sugar for energy.”
According to the article, the researchers used two groups of mice with high-level malignant brain tumors. One group was put on the ketogenic diet while the other stuck to a standard diet; both groups were given radiation treatment. The mice that were put on the ketogenic diet survived much longer than those that stuck to the standard diet.
It went on to say that that the diet therapy could be easily added to treatments for current brain cancer patients, once it passes human trials. The researchers said that the ketogenic diet significantly improves the anti-tumor effect of radiation. In addition, this ketogenic diet is widely available as a formula, mainly designed to treat children with epilepsy.
The article states that the ketogenic diet has been used since the 1920s to treat patients with epilepsy. When the body is on this diet, it is forced to use fat as the main source of energy. The diet’s effect on brain regulation is evidence that it can be used on other brain disorders as well, reports the article.
Clay Darrohn, representative for VABC, said that this is very good news for cancer patients. “This new research is definitely welcome. The more people who commit to positive research, the closer we get to finding a treatment for this devastating disease,” he said.
VABC has a wide variety of initiatives in place for brain cancer research, awareness and support. The organization’s research grants fund cutting-edge research programs that will have a monumental impact on the diagnosis and treatment of brain cancer. VABC currently funds research at several esteemed institutions such as Brookhaven National Laboratory, Cleveland Clinic, Columbia, Cornell, Duke, Harvard, John Hopkins, Memorial Sloan-Kettering and Yale, to name a few.
VABC's mission is to find a cure for brain cancer by advancing scientific research, increasing awareness within the medical community and supporting patients, their families and caregivers afflicted with this devastating disease.
For press inquiries, please contact: 5W Public Relations.